Your browser doesn't support javascript.
loading
The enigmatic ear: Unveiling a rare case of a primary cutaneous CD8+ acral T-cell lymphoproliferative disorder with a literature review.
Sahraoui, Ghada; Sassi, Farah; Charfi, Lamia; Doghri, Raoudha; Mrad, Karima.
Afiliação
  • Sahraoui G; Department of Pathology, Salah Azaiez Institute of Cancer, Tunis, Tunisia.
  • Sassi F; Research Laboratory LR21SP01, Salah Azaiez Institute, Tunis, Tunisia.
  • Charfi L; Department of Pathology, Salah Azaiez Institute of Cancer, Tunis, Tunisia.
  • Doghri R; Department of Pathology, Salah Azaiez Institute of Cancer, Tunis, Tunisia.
  • Mrad K; Research Laboratory LR21SP01, Salah Azaiez Institute, Tunis, Tunisia.
Rare Tumors ; 15: 20363613231204046, 2023.
Article em En | MEDLINE | ID: mdl-37743904
Introduction: Primary cutaneous CD8+ acral T-cell lymphoproliferative disorder (CD8+ ATCLPD) is a rare form of cutaneous T-cell lymphoma that commonly presents on the acral regions of the body. We report a case of a 61-year-old man diagnosed with primary cutaneous CD8+ ATCLPD of the ear. Case presentation: A 61-year-old man presented with a non-healing, erythematous painful macule on the ear that had been evolving for the past 3 months. The lesion was resected, and histopathological examination revealed a primary cutaneous CD8+ ATCLPD with acral localization. Further investigations including CT scan of the thorax, abdomen and pelvis were done to stage the disease. The results showed no extracutaneous involvement. Conclusion: Accurate identification of primary cutaneous CD8+ ATCLPD is crucial due to its distinct prognostic and therapeutic implications compared to other CD8+ cytotoxic lymphoid proliferations. Primary cutaneous CD8+ ATCLPD can be treated conservatively and typically follows a slow clinical course, regardless of the treatment method. Understanding the clinical context, as well as the morphological and immunophenotypic characteristics, can assist in making a precise diagnosis.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Rare Tumors Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Tunísia

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Rare Tumors Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Tunísia